Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision text on the page now shows v3.5.3, replacing v3.5.2. This reflects a minor version update in the site’s revision history.
    Difference
    0.0%
    Check dated 2026-04-30T16:43:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2, replacing v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T09:55:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Core study information appears unchanged; updates are limited to metadata such as the last updated date.
    Difference
    0.1%
    Check dated 2026-04-01T22:38:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added the condition Myelodysplastic/myeloproliferative neoplasm and removed Myeloproliferative neoplasm from the Conditions list; page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:05:25.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-18T11:58:47.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to the page content.
    Difference
    0.1%
    Check dated 2026-03-11T14:22:34.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.